Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor

NCT04596475 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C
Hepatitis C Virus Infection, Response to Therapy of

Interventions

DRUG: glecaprevir/pibrentasvir (GLE/PIB)

Sponsor

University of California, San Diego